Similarly, the discovery of essential checkpoint receptors (including CTLA-4 and PD-1/PD-L1) and their role in immune evasion in cancers, including melanoma, reinvigorated the effort to develop immunotherapies that have proved crucial in prolonging survival [8,9,10,11,12]. The gene discussed is CTLA4; the disease is melanoma.